News and Trends 8 Mar 2023
New bone cancer drug could save children’s lives
Researchers at the University of East Anglia (UEA) in the U.K. have developed a new drug that works against all of the main types of primary bone cancer. Cancer that…
Search Results for: united kingdom
In Depth 14 Sep 2022
Rivaling the Golden Triangle at Bristol’s Science Creates hub
September 15th 2022: Article updated to include comments from Harry Destecroix and to correct a mispelling of Science Creates. The Golden Triangle region hosts much of the U.K.’s biotech innovation….
News and Trends 31 Jan 2023
BiVictriX announces positive data from leukemia study
BiVictriX Therapeutics plc has announced positive in vivo data from a toxicity evaluation study with BVX001, the company’s lead program, compared to gemtuzumab ozogamicin (GO). GO, marketed as Mylotarg, is…
News and Trends 20 May 2019
Update: British RNA Biotech Increases Series A to €34M
Update (20/05/19): Storm Therapeutics has increased its series A financing round by an additional €16M (£14M) to €34M (£30M), which the company plans to use to advance its pipeline of…
ADVERTISEMENT
Best in Biotech 6 Oct 2022
15 biotech companies shaking up the scene in Cambridge
This article was originally published in December 2020 and has since been updated. Cambridge has a large biotech scene that is starting to rival that of its U.S. namesake. Here…
More News! 4 Nov 2022
Alimentiv and Summit collaborate to tackle liver disease NASH
Drug development programs will be driven forward by a collaboration between Alimentiv Inc. and Summit Clinical Research, in a bid to tackle non-alcoholic steatohepatitis (NASH). They announced a strategic alliance…
News and Trends 15 Nov 2022
Researchers create mini ‘bone marrow in a dish’ to boost anti-cancer treatments
Scientists from Oxford University and the University of Birmingham in the U.K. have made the first bone marrow ‘organoids’ that capture the key features of human bone marrow. The technology,…
Expert Advice 2 May 2022
Chief Business Officers: Shedding Light on Biotech’s Dealmakers
In addition to helping patients, biotech companies need to focus on the commercial potential of their work. Stephanie Bewick at Destiny Pharma outlines her experiences of how a Chief Business…
News and Trends 22 Jul 2022
Consortium awarded €4M towards platform for personalized cell therapies
A company developing precision T cell therapies that treat solid tumors announced yesterday (July 21) it is leading a consortium that has been awarded a €4 million ($4.2 million) grant…
Interview 5 Jun 2017
What Lies Ahead in Biotech for the UK’s Top Academic Entrepreneur?
Despite remaining firmly in academia, Greg Winter is a biotech legend. What’s ahead for the serial entrepreneur, and where does he see biotech going? Sir Greg Winter is one of…
News and Trends 26 Apr 2023
aVaxziPen’s needle-free vaccine yields positive data across multiple diseases
aVaxziPen, a biotech company developing a novel needle-free vaccine delivery platform, presented data at the World Vaccine Congress (WVC) in Washington, U.S., recently. The company presented a poster entitled, “Needle-free,…
News and Trends 12 Mar 2018
A Flick of a Switch Can Cause Age-Related Brain Deterioration
Switching certain genes on or off causes the premature aging of stem cells that repair the brain. Identifying them could provide a target for new therapeutic approaches against neurodegenerative diseases….
